Pacira Therapeutics acquires Flexion Therapeutics for $8.50 per share in cash plus one CVR

Oct. 11, 2021 7:13 AM ETPacira BioSciences, Inc. (PCRX)By: Niloofer Shaikh, SA News Editor14 Comments

Pain management documents and stethoscope with book.

designer491/iStock via Getty Images

  • Pacira Therapeutics has acquired Flexion Therapeutics (NASDAQ:FLXN) for $8.50 per share in cash, plus one non-tradeable contingent value right (CVR) worth up to $8.00 per share in cash.
  • The CVR is contingent upon certain sales

Recommended For You

Comments (14)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.